Share this event
BIO-Europe® | Partnerships that drive life science dealmaking
The event will take place digitally from 26 to 29 October 2020.
BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering private, prescheduled virtual one-to-one meetings, as well as digitally-offered workshops and panels, company presentations, and showcasing companies and sponsors.
For more than 25 years EBD Group and its events have played an instrumental role in bringing biopharma and investment leaders together, to facilitate innovation and medical breakthroughs. EBD Group remains fully committed to maintaining its catalytic role helping the global life science community connect and establish these essential partnerships, even when travel and face-to-face meetings are not possible.
Why attend BIO-Europe?
Delegates from all parts of the biotechnology value chain attend BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships.
The BIO-Europe 2020 partnering event is expected to draw over 4,400 industry attendees for three days of high-level networking, representing more than 2,300 companies from over 60 countries. The conference will feature over 26,000 partnering meetings, along with showcasing and presenting companies.
Partnering as an overall business strategy has transformed drug development in bringing together innovators and visionaries with seasoned experts from every corner of the globe. Partnering at BIO-Europe is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners and pre-arrange private one-to-one meetings with dozens of company targets. The system—industry-specific, web-based and interactive—is uniquely suited for the needs of life science companies.
In addition to the program, a key element at our partnering events are the presenting companies and the showcasing companies and sponsors. At BIO-Europe, presenting companies are grouped into several tracks, including Biotech, Midsize Pharma, Next Generation, and Academic Innovators™, with multiple therapeutic areas, digital medicine, cell and gene therapies and medtech represented.
BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization (BIO).